Laura Nevola

Company: IDP Pharma

Job title: Co-Founder, Chief Scientific Officer & Chief Operating Officer

Seminars:

Turning Disordered Proteins “Druggable” with Intrametics TM 9:30 am

Elevating that intrinsically disordered proteins (IDPs) represent half of the human proteins and perform a plethora of biological functions Demonstrating how, IntrameticsTM , IDP Pharma’s proprietary technology, enables for the first-time the inhibition and cellular degradation of IDPs with peptidomimetics Successfully delivering four peptide-derived drug candidates targeting novel IDP targets, with one at clinical stageRead more

day: Conference Day Two